CyttaAIR Partners with FIZUAS to Dominate the American

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
176
CyttaAIR Partners with FIZUAS to Dominate the American Drone Reseller and Advanced Streaming Technology Market

Massive Florida Demand for CyttaCOMMS and Drones Drives Partnership


LAS VEGAS, NV / ACCESSWIRE / June 13, 2024 / Cytta Corp (OTCQB:CYCA), a leading provider of innovative technology solutions for public safety and cybersecurity industries, is excited to announce that CyttaAIR, in an expansion of its longstanding reseller partnership with FIZUAS Unmanned Aircraft Systems, a premier national drone reseller, is now entering the drone reseller market. This strategic joint venture aims to meet the growing demand for American-made drones, particularly from law enforcement agencies transitioning away from foreign drones.

A Strategic Move in Response to Growing Demand

This expanded partnership with FIZUAS comes at a critical time when numerous law enforcement agencies in Florida are seeking guidance on which drone brands and models to purchase. This transition to American-made drones is driven by legislative changes and a heightened focus on data security. Through this joint venture, CyttaAIR will provide these agencies with top-tier, compliant drone options, enhancing their operational capabilities and ensuring adherence to new regulations.

Quote from Mike Elliott, VP of Business Development

"We are thrilled to be partnering with a premiere national drone reseller like FIZUAS," said Mike Elliott, VP of Business Development at Cytta Corp. "The number of law enforcement agencies in Florida asking about which drone brands and models to purchase has skyrocketed. This joint venture allows CyttaAIR to expand into this rapidly growing market, providing our clients with the best in American-made drone technology and our leading CyttaCOMMS secure video streaming solution."

Expanding CyttaAIR's Reach

This collaboration is poised to position CyttaAIR as a dominant player in the drone reseller market. By leveraging FIZUAS's extensive reseller network and expertise, CyttaAIR/FIZUAS will jointly offer a comprehensive range of drones equipped with the secure and collaborative capabilities of CyttaCOMMS. This move underscores Cytta Corp.'s commitment to providing cutting-edge technology solutions that meet the evolving needs of law enforcement and other critical sectors.

About Cytta Corp:

Cytta Corp. is a leading technology solutions provider dedicated to delivering innovative products and services across various industries and revolutionizes the integration, streaming, transfer, and storage of video and audio data. With a focus on safety, security, and efficiency, Cytta Corp strives to develop cutting-edge solutions that address real-world challenges in large markets.

The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency.

About FIZUAS Unmanned Aircraft Systems

FIZUAS is a leading national drone reseller known for providing high-quality, reliable drone solutions to various industries. Their extensive network and extensive first responder and industry expertise make them a trusted partner for organizations looking to integrate drone technology into their operations.

Contact Information
Investor/Shareholder Contact:
Gary Zwetchkenbaum
PlumTree Consulting, LLC.
gzplumtree@gmail.com
Direct: (516)-455-7662

Cytta Corp.
Toll free #: 1 877 CYTTAUS (298 8287)
Call Local: 1 740 CYTTAUS (298 8287)
http://www.cytta.com
info@cytta.com

Gary Campbell, CEO
Direct (702) 900-7022 (or message)
Gary@cytta.com

Mike Elliott, VP of Business Development
mikeelliott@cytta.com
(689) 222-8708

SOURCE: Cytta Corp.

Cytta Corp (CYCA) Stock Research Links

CYCA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gold Prices Climb; Miners Stick to Guidance Amid Stress

Updated Category News Views 110

Wham, pow! Gold's climbing up to the skies again. As if the shiny stuff needed more fanfare, there it is, breaking above $4,000 an ounce. Remember when it couldn't hold a candle to $1,500? Now the December gold futures are planting themselves firmly at $4,124.10. That's a healthy leap from Friday's close by $49.20. How about that for a head-turner? Miners Holding the Line...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
WSIB Slashes Registration Time with Guidewire Boost

Updated Category News Views 63

Quick Fix: Streamlining Ontario's Employer Registration Alright, let's cut through the formalities and tell it like it is: Ontario's Workplace Safety and Insurance Board (WSIB) isn't messing around anymore. They've yanked their antiquated paper-laden process into the digital age, slicing the employer registration wait down from an agonizing eight to ten-day ordeal to a...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 42

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 150

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
Empyrean Eases Public Sector Benefits with OMNIA Deal

Updated Category News Views 126

In a world where bureaucratic red tape often chokes efficiency, Empyrean throws a lifeline to public sector bodies. They've nabbed a cooperative purchasing contract with OMNIA Partners, dialing down the procurement guts to make benefits administration easier for government and education folks. Streamlining Public Sector Procurement Public sector organizations ain't...

Continue Reading
Smart Cooling Accessory: A Game Changer for AC Units?

Updated Category News Views 76

New Kid on the Block: The Smart Cooling Game They say the devil's in the details, and this one’s got all the right tweaks. Picture this — a compressor-based air conditioning system beefing up with a savvy accessory that promises to give your condenser coil some extra muscle. That's right, we've got ourselves a new contender in the cooling corner: THE CSC UNIT. It's...

Continue Reading
QuidelOrtho Shares Plunge 14% Amid Legal Scrutiny

Updated Category News Views 25

QuidelOrtho's Rocky Road Oh, it's been a roller coaster for QuidelOrtho's stock. Lately, it’s like holding onto a greased pole in a thunderstorm. November 9th, 2026, wasn't a friend to QDEL shareholders; the stock's down about 14%, and now some legal eagles want to know if there's more to the story. When you go poking around in the financials and spotlight that nasty...

Continue Reading
Children's Institute Gala Raises $4M: A Night to Remember

Updated Category News Views 82

Breaking Records and Honoring Legends You know, sometimes there's more to the world than stocks and ticker tapes. Over in Los Angeles, the Children's Institute pulled off a real spectacle with their Annual Cape & Gown Gala, drawing in more than 600 folks and raking in a whopping $4 million. That's right, four million clams in one evening—a record-breaker for them. When...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 146

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading

Top 5 Most Recently Viewed Articles

Oakworth Capital Inc. Delivers Consistent Annual Dividend Growth

Updated Category News Views 149

Oakworth Capital Inc. Declares Annual Dividend The Board of Directors of Oakworth Capital Inc. met recently and announced a notable achievement: an annual dividend of $0.45 per common share. This marks the 10th consecutive year that the company has provided a cash dividend to its shareholders, showcasing their commitment to returning value to investors. Amazing...

Continue Reading
SELLAS Life Sciences Group Targets Major Milestones Ahead

Updated Category News Views 204

SELLAS Life Sciences Group Moves Forward with Cancer Research SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) is taking significant steps in advancing its cancer therapies, aiming for pivotal milestones that are expected in the coming years. With a market capitalization of approximately $74 million, this late-stage clinical biopharmaceutical company is on the verge of...

Continue Reading
Fortran Corporation's Strategic Move to Acquire Intech Systems

Updated Category News Views 152

Fortran Corporation Makes Significant Acquisition Move Fortran Corporation (OTC: FRTN) has recently signed a Letter of Intent (LOI) that heralds a promising new chapter for the company. This LOI is aimed at acquiring Intech Systems of South Carolina, Inc., a significant player in telecommunication sales and services. Impacts of the Acquisition The company’s President,...

Continue Reading
Action Alert: Novo Nordisk (NYSE: NVO) Investors Required to Act Soon

Updated Category News Views 164

Urgent Notice for Novo Nordisk (NYSE: NVO) Investors As the situation develops, investors in Novo Nordisk A/S, a renowned global pharmaceutical company, are advised to stay informed about a potential securities fraud class action. This comes in light of recent legal challenges aimed at the company, and those holding Novo securities need to take notice. Investor Action...

Continue Reading
Galan Lithium Secures A$20 Million Commitment from Clean Elements

Updated Category News Views 303

Galan Lithium Limited Announces Strategic A$20 Million Placement Galan Lithium Limited (ASX:GLN) is excited to share that it has successfully obtained a binding commitment for a significant A$20 million placement at A$0.11 per share. This represents a remarkable 21% premium over the most recent closing price of A$0.091, showcasing the confidence investors have in the...

Continue Reading